Free Trial

NeuroOne Medical Technologies Q2 2023 Earnings Report

NeuroOne Medical Technologies logo
$1.05 +0.01 (+0.95%)
As of 01/17/2025 04:00 PM Eastern

NeuroOne Medical Technologies EPS Results

Actual EPS
-$0.21
Consensus EPS
N/A
Beat/Miss
N/A
One Year Ago EPS
N/A

NeuroOne Medical Technologies Revenue Results

Actual Revenue
$0.47 million
Expected Revenue
N/A
Beat/Miss
N/A
YoY Revenue Growth
N/A

NeuroOne Medical Technologies Announcement Details

Quarter
Q2 2023
Time
N/A

Conference Call Resources

NeuroOne Medical Technologies Earnings Headlines

This Crypto Is Set to Explode in January
It's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this surge is a massive new blockchain development…
NeuroOne Announces Preliminary Q1 Fiscal 2025 Revenue Of $6.2 Mln
See More NeuroOne Medical Technologies Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like NeuroOne Medical Technologies? Sign up for Earnings360's daily newsletter to receive timely earnings updates on NeuroOne Medical Technologies and other key companies, straight to your email.

About NeuroOne Medical Technologies

NeuroOne Medical Technologies (NASDAQ:NMTC), a developmental stage company, provides solutions for EEG recording, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, and chronic pain due to failed back surgeries and other related neurological disorders. It also fucuses on applications for other areas, such as depression, mood disorders, pain, incontinence, high blood pressure, and artificial intelligence. It has a strategic partnership with RBC Medical Innovations to develop a radio frequency ablation generator. The company was incorporated in 2009 and is based in Eden Prairie, Minnesota.

View NeuroOne Medical Technologies Profile

More Earnings Resources from MarketBeat